603392 Stock Overview
Beijing Wantai Biological Pharmacy Enterprise Co., Ltd. More details
| Snowflake Score | |
|---|---|
| Valuation | 1/6 |
| Future Growth | 5/6 |
| Past Performance | 0/6 |
| Financial Health | 5/6 |
| Dividends | 0/6 |
Rewards
Risk Analysis
No risks detected for 603392 from our risk checks.
My Notes
Capture your thoughts, links and company narrative
Beijing Wantai Biological Pharmacy Enterprise Co., Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CN¥76.30 |
| 52 Week High | CN¥89.89 |
| 52 Week Low | CN¥47.62 |
| Beta | 2.26 |
| 1 Month Change | 4.28% |
| 3 Month Change | 10.20% |
| 1 Year Change | 18.22% |
| 3 Year Change | -32.50% |
| 5 Year Change | n/a |
| Change since IPO | 1,620.99% |
Recent News & Updates
Recent updates
Beijing Wantai Biological Pharmacy Enterprise Co., Ltd. (SHSE:603392) Analysts Are Reducing Their Forecasts For This Year
Jul 26
These 4 Measures Indicate That Beijing Wantai Biological Pharmacy Enterprise (SHSE:603392) Is Using Debt Reasonably Well
Jul 22Some Investors May Be Willing To Look Past Beijing Wantai Biological Pharmacy Enterprise's (SHSE:603392) Soft Earnings
Apr 04Things Look Grim For Beijing Wantai Biological Pharmacy Enterprise Co., Ltd. (SHSE:603392) After Today's Downgrade
Apr 02Earnings Tell The Story For Beijing Wantai Biological Pharmacy Enterprise Co., Ltd. (SHSE:603392) As Its Stock Soars 27%
Feb 28Shareholder Returns
| 603392 | CN Biotechs | CN Market | |
|---|---|---|---|
| 7D | 1.2% | -1.9% | -1.2% |
| 1Y | 18.2% | -16.2% | 11.8% |
Return vs Industry: 603392 exceeded the CN Biotechs industry which returned -16.2% over the past year.
Return vs Market: 603392 exceeded the CN Market which returned 11.8% over the past year.
Price Volatility
| 603392 volatility | |
|---|---|
| 603392 Average Weekly Movement | 5.4% |
| Biotechs Industry Average Movement | 8.8% |
| Market Average Movement | 8.7% |
| 10% most volatile stocks in CN Market | 12.8% |
| 10% least volatile stocks in CN Market | 5.7% |
Stable Share Price: 603392 has not had significant price volatility in the past 3 months compared to the CN market.
Volatility Over Time: 603392's weekly volatility (5%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1991 | 3,710 | Zhiming Jiang | www.ystwt.com |
Beijing Wantai Biological Pharmacy Enterprise Co., Ltd. research, develops, produces, distributes, and sells infectious disease diagnostic reagents and vaccines in China and internationally. The company provides chemiluminescence series, assembly line series, nucleic acid series, dry type fluorescent immunoassay, and fully automatic blood type analyzer and reagents; ELISA kits; rapid diagnosis; bole series; and supporting reagents.
Beijing Wantai Biological Pharmacy Enterprise Co., Ltd. Fundamentals Summary
| 603392 fundamental statistics | |
|---|---|
| Market cap | CN¥96.53b |
| Earnings (TTM) | -CN¥294.04m |
| Revenue (TTM) | CN¥2.49b |
38.8x
P/S Ratio-328.3x
P/E RatioIs 603392 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 603392 income statement (TTM) | |
|---|---|
| Revenue | CN¥2.49b |
| Cost of Revenue | CN¥959.58m |
| Gross Profit | CN¥1.53b |
| Other Expenses | CN¥1.82b |
| Earnings | -CN¥294.04m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.23 |
| Gross Margin | 61.46% |
| Net Profit Margin | -11.81% |
| Debt/Equity Ratio | 2.1% |
How did 603392 perform over the long term?
See historical performance and comparisonDividends
0.4%
Current Dividend Yield-138%
Payout RatioCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/22 07:04 |
| End of Day Share Price | 2024/12/20 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Beijing Wantai Biological Pharmacy Enterprise Co., Ltd. is covered by 9 analysts. 2 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Bo Li | BofA Global Research |
| Zhizhong Jing | China Merchants Securities Co. Ltd. |
| Wei Sun | China Merchants Securities Co. Ltd. |